InVivoMab anti-mouse NKG2D BE0111-R001mg from Bio X Cell

Other available quantities: Available in 1, 5, 10, 25, 50, 100 mg and bulk sizes. Academic discount available.

Endotoxin: <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bxcell.com

(3) NKG2D blockade attenuated cardiac allograft vasculopathy in a mouse model of cardiac transplantationClinical and experimental immunologySeptember 1, 2013Chen H, Xia J, Zhang L, Jin X, Yang M, Li J, Zhao Y.

(4) Promotion of liver regeneration by natural killer cells in a murine model is dependent on extracellular adenosine triphosphate phosphohydrolysisHepatology (Baltimore, Md.)May 1, 2013Graubardt N, Fahrner R, Trochsler M, Keogh A, Breu K, Furer C, Stroka D, Robson SC, Slack E, Candinas D, et al.

(5) Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growthThe Journal of investigative dermatologyFebruary 1, 2013Hervieu A, Rébé C, Végran F, Chalmin F, Bruchard M, Vabres P, Apetoh L, Ghiringhelli F, Mignot G.

(6) NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responsesNature medicineFebruary 26, 2012Zloza A, Kohlhapp FJ, Lyons GE, Schenkel JM, Moore TV, Lacek AT, O'Sullivan JA, Varanasi V, Williams JW, Jagoda MC, et al.

(7) IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistencePLoS pathogensJanuary 1, 2012Mandaric S, Walton SM, Rülicke T, Richter K, Girard-Madoux MJ, Clausen BE, Zurunic A, Kamanaka M, Flavell RA, Jonjic S, et al.

(8) NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathwayInternational immunologyOctober 1, 2008Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K.

InVivoMab anti-mouse NKG2D